Korea 2021 Roundup: License Deals, Overseas Sales Key Factors In Earnings

Hanmi, GC Pharma, SK Affiliates Strong Performers

earnings
As Korean Pharmas Globalize, License Deal, Overseas Sales Impact Grow • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia